The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

In Europe, meanwhile, Regeneron’s PD-1 inhibitor Libtayo (cemiplimab) is indicated as a second-line therapy for recurrent or advanced cervical cancer, regardless of PD-L1 expression status, ...

The risk of recurrence was generally low among cervical cancer patients with no high-risk factors who underwent radical surgery without adjuvant therapy.

At-home screenings are effective alternatives for closing the screening gap. One study found that mailing kits to people ...

The Teal Wand is an at-home vaginal sample self-collection device that tests for HPV. The test will first be available in ...

Teal Health has made an at-home test that screens for human papillomavirus (HPV), the virus that causes nearly all cervical cancers.

To get screened for cervical cancer, patients in the United States may no longer need to put their feet in those awkward ...

Indigenously developed (Human papillomavirus) HPV test kits for cervical cancer screening were launched on Wednesday (April 23, 2025). The test kits have been developed under the Department of ...

Teal Health, the maker of an at-home cervical cancer screening test, says it will give patients an alternative to in-clinic pap smears.

The U.S. Food and Drug Administration has approved the first at-home test for cervical cancer screening, its maker Teal ...

The study titled 'Validation of Indigenous Human Papillomavirus Tests for Cervical Cancer Screening in India (i-HPV)' validated indigenously developed, rapid, point-of-care, RTPCR-based HPV ...